ScholarIQanswers from OpenAlex
Hospital São Paulo
InstitutionResearch output, impact & collaborations
Hospital São Paulo is a institution indexed in ScholarIQ from OpenAlex.
What is known about Hospital São Paulo?
ScholarIQrecord summary
Hospital São Paulo is a research organisation in São Paulo, BR. OpenAlex records 8,431 works and 375,740 citations for it. 3,579 researchers list it as their most recent affiliation.
How many works does Hospital São Paulo have?
ScholarIQindexed works
Hospital São Paulo has 8,431 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Hospital São Paulo have?
ScholarIQcitation count
Hospital São Paulo has 375,740 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Hospital São Paulo?
ScholarIQresearcher count
Hospital São Paulo has 3,579 researchers in the ScholarIQ index.
What is the average h-index at Hospital São Paulo?
ScholarIQavg h-index
Hospital São Paulo has an average h-index of 76 in OpenAlex.
What is the ROR of Hospital São Paulo?
ScholarIQror
The ROR for Hospital São Paulo is on the source record.
What is the OpenAlex record for Hospital São Paulo?
ScholarIQopenalex
The OpenAlex for Hospital São Paulo is on the source record.
Who are the most-cited researchers behind Hospital São Paulo?
ScholarIQtop researchers by citations
What are the most-cited papers on Hospital São Paulo?
ScholarIQmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andrej Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Mark C. Petrie, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Subodh Verma, Claes Held, David L. DeMets, Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, Mikaela Sjöstrand, Anna-Maria Langkilde
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca, Deepak L. Bhatt, Marc Cohen, Philippe Gabríel Steg, Robert F. Storey, Eva C. Jensen, Giulia Magnani, Sameer Bansilal, M. Polly Fish, KyungAh Im, Olof Bengtsson, Ton Oude Ophuis, Andrzej Budaj, Pierre Théroux, Mikhail Ruda, Christian Hamm, Shinya Goto, Jindřich Špinar, José Carlos Nicolau, Róbert Gábor Kiss, Sabina A. Murphy, Stephen Wiviott, Peter Held, Eugene Braunwald, Marc S. Sabatine
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
David A. Morrow, Eugene Braunwald, Marc P. Bonaca, Sebastián F. Ameriso, Anthony J. Dalby, Mary Polly Fish, Keith A.A. Fox, Leslie Lipka, Xuan Liu, José Carlos Nicolau, A.J. Oude Ophuis, Ernesto Paolasso, Benjamin M. Scirica, Jindřich Špinar, Pierre Théroux, Stephen D. Wiviott, John Strony, Sabina A. Murphy
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
Robert O. Bonow, Gerald Maurer, Kerry L. Lee, Thomas A. Holly, Philip F. Binkley, Patrice Desvigne‐Nickens, Jarosław Dróżdż, Pedro Sílvio Farsky, Arthur M. Feldman, Torsten Doenst, Robert E. Michler, Daniel S. Berman, José Carlos Nicolau, Patricia A. Pellikka, Krzysztof Wróbel, Nasri Alotti, Federico M. Asch, Liliana E. Favaloro, Lilin She, Eric J. Velazquez, Robert H. Jones, Julio A. Panza
How much of the research on Hospital São Paulo is open access?
ScholarIQopen access share
92%OPEN ACCESS